The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
p53 mutations in colorectal cancer.
Open accessAbstract
Immunohistological staining of primary colorectal carcinomas with antibodies specific to p53 demonstrated gross overexpression of the protein in approximately 50% of the malignant tumors examined. Benign adenomas were all negative for p53 overexpression. To determine the molecular basis for this overexpression we examined p53 protein expression in 10 colorectal cancer cell lines. Six of the cell lines expressed high levels of p53 in ELISA, cell-staining, and immunoprecipitation studies. Direct sequencing and chemical-mismatch-cleavage analysis of p53 cDNA by using the polymerase chain reaction in these cell lines showed that all cell lines that expressed high levels of p53 were synthesizing mRNAs that encoded mutant p53 proteins. In two of those four cell lines where p53 expression was lower, point mutations were still detected. Thus, we conclude that overexpression of p53 is synonymous with mutation, but some mutations would not be detected by a simple immunohistochemical analysis. Mutation of the p53 gene is one of the commonest genetic changes in the development of human colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Gyllensten, U. B., & Erlich, H. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7652 · Cited by 1,560
Localization of the gene for familial adenomatous polyposis on chromosome 5
Bodmer, W. F., Bailey, C. J., Bodmer, J., Bussey, H. J. R., Ellis, A., Gorman, P., Lucibello, F. C., Murday, V. A., Rider, S. H., Scambler, P., et al. (1987) · Nature · doi:10.1038/328614a0 · Cited by 1,390
Self-citationp53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Monoclonal antibodies specific for simian virus 40 tumor antigens
Harlow, E., Crawford, L. V., Pim, D. C., & Williamson, N. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.861-869.1981 · Cited by 1,039
Increased expression of mutant forms of p53 oncogene in primary lung cancer
Iggo, R., Bartek, J., Lane, D., Gatter, K., Harris, A. L., & Bartek, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90801-b · Cited by 1,031
Self-citationClassification of human colorectal adenocarcinoma cell lines.
Leibovitz, A., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., & Mabry, N. D. (1976) · PubMed · Cited by 949
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Self-citationMonoclonal Antibodies for Analysis of the HLA System
Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., & BOdmer, W. F. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00288.x · Cited by 733
Self-citationGannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Self-citationMinowada, J., ONUMA, T., & Moore, G. E. (1972) · PubMed · Cited by 646
Clonal Analysis of Human Colorectal Tumors
Fearon, E. R., Hamilton, S. R., & Vogelstein, B. (1987) · Science · doi:10.1126/science.2889267 · Cited by 628
Cotton, R. G., Rodrigues, N. R., & Campbell, R. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4397 · Cited by 620
Self-citationGenetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Bártek, J., Iggo, R. D., Gannon, J., & Lane, D. P. (1990) · PubMed · Cited by 603
Self-citationP53 expression in breast cancer
Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410204 · Cited by 601
BANKS, L., MATLASHEWSKI, G., & CRAWFORD, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 495
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Human colonic adenocarcinoma cells: I. Establishment and description of a new line
Tom, B. H., Rutzky, L. P., Jakstys, M. M., Oyasu, R., Kaye, C. I., & Kahan, B. D. (1976) · In Vitro · doi:10.1007/bf02796440 · Cited by 378
Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284
Dexter, D. L., Barbosa, J. A., & Calabresi, P. (1979) · PubMed · Cited by 266
Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.
Crawford, L. V., Pim, D. C., Gurney, E. G., Goodfellow, P., & Taylor-Papadimitriou, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.41 · Cited by 236
Characterization of WiDr: A human colon carcinoma cell line
Noguchi, P., Wallace, R., Johnson, J., Earley, E. M., O'Brien, S., Ferrone, S., Pellegrino, M. A., Milstien, J., Needy, C., Browne, W., et al. (1979) · In Vitro · doi:10.1007/bf02618407 · Cited by 168
Direct detection of point mutations by mismatch analysis: application to haemophilia B
Montandon, A. J., Green, P. M., Giannelli, F., & Bently, D. R. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.9.3347 · Cited by 164
Paraskeva, C., Buckle, B. G., Sheer, D., & Wigley, C. B. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340109 · Cited by 138
Precise epitope mapping of the murine transformation‐associated protein, p53.
Wade-Evans, A. M., & Jenkins, J. R. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03686.x · Cited by 128
Smith, M. E., Marsh, S. G. E., Bodmer, J. G., Gelsthorpe, K., & Bodmer, W. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5557 · Cited by 122
Self-citationBall, R. K., Siegl, B., Quellhorst, S., Brandner, G., & Braun, D. G. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02000.x · Cited by 104
Milner, J., Cook, A., & Sheldon, M. J. (1987) · PubMed · Cited by 78
Cited by
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Metadata
- Authors
- Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., & Lane, D. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-10
- Volume
- 87
- Issue
- 19
- Pages
- 7555-7559
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2040876807
- Cited by
- 1,003
- References
- 31
- FWCI
- 30.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.